SCHEMBL12794026

SCHEMBL12794026

[2H]C([2H])(C)c1ncnn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11892769 0.77 — —
SCHEMBL13830911 0.71 — —
SCHEMBL19129203 0.71 HTR1A (0.39) —
SCHEMBL11890333 0.71 GABRA1 (0.33) —
SCHEMBL12722531 0.70 HTR1A (0.38) —
SCHEMBL15308486 0.69 HTR1A (0.35) —
SCHEMBL7269638 0.66 TLR7 (0.33) —
SCHEMBL31282565 0.66 KDM4E (0.33) —
SCHEMBL308793 0.65 — —
SCHEMBL2041363 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501738-B2 Substituted triazolo-pyridazine derivatives CONCERT PHARMACEUTICALS, INC. (US) 2013-08-06 — — US disclosed
US-20110065711-A1 SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2011-03-17 — — US disclosed
Send feedback